Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
23 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Pharma Two B Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Pharma Two B Ltd - Product Pipeline Review - 2014', provides an overview of the Pharma Two B Ltd's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Pharma Two B Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Pharma Two B Ltd including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Pharma Two B Ltd's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Pharma Two B Ltd's pipeline products Reasons to buy - Evaluate Pharma Two B Ltd's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Pharma Two B Ltd in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Pharma Two B Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Pharma Two B Ltd and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pharma Two B Ltd - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Pharma Two B Ltd and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Pharma Two B Ltd Snapshot 4 Pharma Two B Ltd Overview 4 Key Information 4 Key Facts 4 Pharma Two B Ltd - Research and Development Overview 5 Key Therapeutic Areas 5 Pharma Two B Ltd - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Combination Treatment Modalities 9 Pharma Two B Ltd - Pipeline Products Glance 10 Pharma Two B Ltd - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Pharma Two B Ltd - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Pharma Two B Ltd - Drug Profiles 12 (pramipexole + rasagiline) 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 P2B-002 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 P2B-003 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 P2B-004 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Pharma Two B Ltd - Pipeline Analysis 16 Pharma Two B Ltd - Pipeline Products by Target 16 Pharma Two B Ltd - Pipeline Products by Route of Administration 17 Pharma Two B Ltd - Pipeline Products by Molecule Type 18 Pharma Two B Ltd - Pipeline Products by Mechanism of Action 19 Pharma Two B Ltd - Recent Pipeline Updates 20 Pharma Two B Ltd - Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 23 Disclaimer 23
List of Tables Pharma Two B Ltd, Key Information 4 Pharma Two B Ltd, Key Facts 4 Pharma Two B Ltd - Pipeline by Indication, 2014 6 Pharma Two B Ltd - Pipeline by Stage of Development, 2014 7 Pharma Two B Ltd - Monotherapy Products in Pipeline, 2014 8 Pharma Two B Ltd - Combination Treatment Modalities in Pipeline, 2014 9 Pharma Two B Ltd - Phase II, 2014 10 Pharma Two B Ltd - Preclinical, 2014 11 Pharma Two B Ltd - Pipeline by Target, 2014 16 Pharma Two B Ltd - Pipeline by Route of Administration, 2014 17 Pharma Two B Ltd - Pipeline by Molecule Type, 2014 18 Pharma Two B Ltd - Pipeline Products by Mechanism of Action, 2014 19 Pharma Two B Ltd - Recent Pipeline Updates, 2014 20
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.